DUBLIN–(BUSINESS WIRE)–The “Electrophoresis
Reagents Market – Growth, Trends, and Forecast (2019 – 2024)”
report has been added to ResearchAndMarkets.com’s
offering.
The propelling factors for the growth of the electrophoresis reagents
market include the increased funding for genomic and proteomic research,
the rising prevalence of chronic diseases, increasing collaborations
between industry and academics, and the technological developments.
The prevalence of chronic diseases is expected to increase by 57% by
2020. Additionally, as per WHO, China and India now have the world’s
highest number of diabetes sufferers at more than 98 million and 65
million individuals. With the increasing prevalence of chronic diseases,
prompt diagnosis and treatment are in need.
Therefore, this has given rise to the electrophoresis that is used in
the clinical laboratories to quantify the lipoproteins using enzymatic
staining of cholesterol and triglycerides for the diagnosis of CVD and
other chronic diseases, like diabetes. The electrophoresis is used in
the analysis of the lipoproteins and apolipoproteins that are essential
for the valuation of the CVD and monitoring of individuals on treatment.
Furthermore, the development of this market is also significantly
determined by the expanding research exercises in the fields of
proteomics and genomics, changing administrative necessities in the
pharmaceutical part, and the developing need to reduce the healthcare
expenses.
Moreover, factors like rising per capita income and increasing public
healthcare expenditure are also expected to promote the growth of
electrophoresis reagents market over the forecast period.
Key Market Trends
Gel Electrophoresis is the Largest Segment Under Technique That is
Also Expected to Continue During the Forecast Period
Gel electrophoresis segment accounted for the largest market share of
electrophoresis reagents market, mainly due to the low operating and
instrument cost. It is, thus, being followed by capillary
electrophoresis, because of rising applications in the pharmaceutical
and biotechnology industries.
Asia-Pacific Region is the Fastest Growing Market and is Expected to
Follow the Same Trend Over the Forecast Period
The Asia-Pacific region is expected to dominate the electrophoresis
reagents market. In the emerging economies of China, Japan, and India,
there has been an increasing number of academic and research
institutions, technological advancements, pharmaceutical, and
biotechnology companies, and health awareness. The high growth is also
majorly attributed to the rapidly improving healthcare infrastructure
and low labor costs in emerging countries.
Competitive Landscape
The major players are found adopting various strategies, such as
agreements, expansion, contracts, partnerships, new reagent development,
joint ventures, and mergers and acquisitions in order to strengthen
their position in the electrophoresis reagents market.
Key Topics Covered
1 INTRODUCTION
1.1 Study Deliverables
1.2
Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2
Market Drivers
4.2.1 Increasing Funding for Genomic and Proteomic
Research
4.2.2 Rising Prevalence of Chronic Diseases
4.2.3
Increasing Collaborations between Industry and Academics
4.2.4
Technological Developments
4.3 Market Restraints
4.3.1
Time-consuming Operations
4.3.2 Presence of Alternative Technologies
4.4
Porter’s Five Forces Analysis
5 MARKET SEGMENTATION
5.1 By Product
5.1.1
Gels
5.1.1.1 Agarose Gels
5.1.1.2 Polyacrylamide Gels
5.1.1.3
Starch Gels
5.1.2 Dyes
5.1.2.1 Ethidium Bromide (ETBR) Dyes
5.1.2.2
Bromophenol Blue
5.1.2.3 Sybr Dyes
5.1.2.4 Other Dyes
5.1.3
Buffers
5.1.3.1 Tris/Acetate/EDTA
5.1.3.2 Tris/Borate/EDTA
5.1.3.3
Other Buffers
5.1.4 Other Products
5.2 By Technique
5.2.1
Gel Electrophoresis
5.2.2 Capillary Electrophoresis
5.3 By End
User
5.3.1 Academic and Research Institutions
5.3.2
Pharmaceutical and Biotechnology Companies
5.3.3 Laboratories
5.3.4
Other End Users
5.4 Geography
5.4.1 North America
5.4.2
Europe
5.4.3 Asia-Pacific
5.4.4 Middle East & Africa
5.4.5
South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1
Agilent Technologies Inc.
6.1.2 BioAtlas
6.1.3 Bio-Rad
Laboratories Inc.
6.1.4 GE Healthcare
6.1.5 Lonza Group AG
6.1.6
Merck KGaA
6.1.7 Qiagen N.V.
6.1.8 Sigma-Aldrich Corporation
6.1.9
Takara Bio Inc.
6.1.10 Thermo Fisher Scientific
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/afzbzo
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Biotechnology